Astellas Collaborates with Chromatin Bioscience to Develop Cell-Selective Synthetic Promoters
Shots:
- Astellas has entered into a collaboration agreement with Chromatin Bioscience to design cell-selective synthetic promoters
- As per the agreement, Chromatin will utilize its chromatinLENS platform to develop cell-selective synthetic promoters for Astellas’ target profile, allowing precise & durable gene expression in specific cells
- chromatinLENS platform identifies gene regulatory elements from the dark genome & designs synthetic promoters for targeted use across therapeutics, agritech, industrial biotech as well as bioprocessing sectors
Ref: Prnewswire | Image: Chromatin Bioscience & Astellas
Related News:- Astellas to Establish Joint Venture with YASKAWA for Cell Therapy Manufacturing
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Ridhi is an avid secondary researcher who follows trends in the biopharmaceutical and healthcare sectors to curate engaging content for the global audience. She works as a news editor at PharmaShots and loves to read books and explore new destinations.
